Literature DB >> 34142714

The angiotensin converting enzyme 2 (ACE2) system in the brain: possible involvement in Neuro-Covid.

Oliver von Bohlen Und Halbach1.   

Abstract

The brain has its own intrinsic renin-angiotensin system (RAS) with all its components present in the central nervous system (CNS). Recent data demonstrate that also the main components of the angiotensin concerting enzyme 2 (ACE2) system (at least ACE2 itself, as well as the biologically active angiotensin (1-7) and its cognate receptor Mas) are expressed in the brain. Aside from these members, alamadine and MrgD are discussed as further members that have neuro-active roles in the CNS. Little is known about the possible functions of MrgD within the brain. Concerning angiotensin (1-7) acting through the Mas receptor, data were accumulating that this system is involved in numerous processes contributing to neuronal plasticity and even learning and memory. Malfunctions in the brain ACE2 system are associated with disturbances in neuronal plasticity. Since SARS-CoV-2 has a high affinity towards ACE2, Neuro-Covid may directly or indirectly depend on a disturbed balance in the ACE2 derived angiotensin system in the brain. Since the ACE2 system in the brain is far from being understood, a deeper understanding of e.g. the angiotensin (1-7) / Mas system is needed, especially with regard to the roles of angiotensin (1-7) in neuronal plasticity.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34142714     DOI: 10.14670/HH-18-356

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  62 in total

Review 1.  Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.

Authors:  Mukta Agrawal; Swarnlata Saraf; Shailendra Saraf; Sophia G Antimisiaris; Mahavir Bhupal Chougule; Sunday A Shoyele; Amit Alexander
Journal:  J Control Release       Date:  2018-05-24       Impact factor: 9.776

2.  Angiotensin-(1-7) central administration induces anxiolytic-like effects in elevated plus maze and decreased oxidative stress in the amygdala.

Authors:  Walther Bild; Alin Ciobica
Journal:  J Affect Disord       Date:  2012-08-04       Impact factor: 4.839

Review 3.  MAS and its related G protein-coupled receptors, Mrgprs.

Authors:  Michael Bader; Natalia Alenina; Miguel A Andrade-Navarro; Robson A Santos
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

4.  Alamandine through MrgD receptor induces antidepressant-like effect in transgenic rats with low brain angiotensinogen.

Authors:  Ana F Almeida-Santos; Leonardo A de Melo; Sthéfanie C A Gonçalves; Laura B Oliveira Amaral; Robson A S Santos; Maria José Campagnole-Santos; Lucas M Kangussu
Journal:  Horm Behav       Date:  2020-11-03       Impact factor: 3.587

5.  Altered Serum Levels of Renin-Angiotensin System Markers in Migraine.

Authors:  Laís Bhering Martins; Aline Silva de Miranda; Ana Maria Dos Santos Rodrigues; Jenneffer Rayane Braga Tibaes; Rodrigo Santiago Gomez; Adaliene Versiani Matos Ferreira; Antonio Lúcio Teixeira
Journal:  Headache       Date:  2020-09-02       Impact factor: 5.887

6.  Protective effects of the angiotensin II AT2 receptor agonist compound 21 in ischemic stroke: a nose-to-brain delivery approach.

Authors:  Douglas M Bennion; Chad H Jones; Alex N Dang; Jacob Isenberg; Justin T Graham; Lena Lindblad; Oliver Domenig; Michael F Waters; Marko Poglitsch; Colin Sumners; Ulrike Muscha Steckelings
Journal:  Clin Sci (Lond)       Date:  2018-03-15       Impact factor: 6.124

7.  Evaluation of direct transport pathways of glycine receptor antagonists and an angiotensin antagonist from the nasal cavity to the central nervous system in the rat model.

Authors:  Stuart T Charlton; Joanne Whetstone; Susan T Fayinka; Kevin D Read; Lisbeth Illum; Stanley S Davis
Journal:  Pharm Res       Date:  2008-02-22       Impact factor: 4.200

8.  In vitro and in vivo evaluation of levodopa-loaded nanoparticles for nose to brain delivery.

Authors:  Sema Arisoy; Ozgun Sayiner; Tansel Comoglu; Deniz Onal; Ozbeyen Atalay; Bilge Pehlivanoglu
Journal:  Pharm Dev Technol       Date:  2020-03-18       Impact factor: 3.133

9.  Disentangling the Hypothesis of Host Dysosmia and SARS-CoV-2: The Bait Symptom That Hides Neglected Neurophysiological Routes.

Authors:  Matteo Briguglio; Alberto Bona; Mauro Porta; Bernardo Dell'Osso; Fabrizio Ernesto Pregliasco; Giuseppe Banfi
Journal:  Front Physiol       Date:  2020-06-05       Impact factor: 4.566

Review 10.  Roles and functions of Atp6ap2 in the brain.

Authors:  Alexander Bracke; Oliver von Bohlen Und Halbach
Journal:  Neural Regen Res       Date:  2018-12       Impact factor: 5.135

View more
  3 in total

1.  Localization and expression of the Mas-related G-protein coupled receptor member D (MrgD) in the mouse brain.

Authors:  Javad Hami; Viola von Bohlen Und Halbach; Anja Tetzner; Thomas Walther; Oliver von Bohlen Und Halbach
Journal:  Heliyon       Date:  2021-11-18

Review 2.  Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation.

Authors:  Anthony J Turner; Natalia N Nalivaeva
Journal:  Peptides       Date:  2022-02-10       Impact factor: 3.750

3.  COVID-19 causes neuronal degeneration and reduces neurogenesis in human hippocampus.

Authors:  Amir-Hossein Bayat; Helia Azimi; Meysam Hassani Moghaddam; Vahid Ebrahimi; Mobina Fathi; Kimia Vakili; Gholam-Reza Mahmoudiasl; Mahdi Forouzesh; Mahdi Eskandarian Boroujeni; Zahra Nariman; Hojjat-Allah Abbaszadeh; Arefeh Aryan; Abbas Aliaghaei; Mohammad-Amin Abdollahifar
Journal:  Apoptosis       Date:  2022-07-25       Impact factor: 5.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.